Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting

Background: To compare the effects of empagliflozin and linagliptin use on kidney outcomes of type 2 diabetes mellitus (T2DM) patients in a real-world setting. Methods: The study involved a propensity score-matched cohort comprising new users of empagliflozin or linagliptin with T2DM between January...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yueh-Ting, Hsu, Chien-Ning, Fu, Chung-Ming, Wang, Shih-Wei, Huang, Chiang-Chi, Li, Lung-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724779/
https://www.ncbi.nlm.nih.gov/pubmed/34992535
http://dx.doi.org/10.3389/fphar.2021.781379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724779/
https://www.ncbi.nlm.nih.gov/pubmed/34992535
http://dx.doi.org/10.3389/fphar.2021.781379

Ejemplares similares